Latest & greatest articles for nifedipine

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on nifedipine or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on nifedipine and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for nifedipine

1. Nifedipine

Nifedipine Top results for nifedipine - Trip Database or use your Google+ account Liberating the literature My query is: English Français Deutsch Čeština Español Magyar Svenska ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing (...) the search button. An example search might look like (#1 or #2) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for nifedipine The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines

Trip Latest and Greatest2018

2. Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial

Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial 28867601 2017 12 11 2018 01 11 1097-6868 217 6 2017 12 American journal of obstetrics and gynecology Am. J. Obstet. Gynecol. Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial. 687.e1-687.e6 S0002-9378(17)30965-1 10.1016/j.ajog.2017.08.018 There is a paucity of good quality evidence regarding the best therapeutic option for acute control (...) of blood pressure during acute hypertensive emergency of pregnancy. We sought to compare the efficacy of intravenously administered hydralazine and oral nifedipine for acute blood pressure control in acute hypertensive emergency of pregnancy. In this double-blind, randomized, controlled trial, pregnant women (≥24 weeks period of gestation) with sustained increase in systolic blood pressure of ≥160 mm Hg or diastolic blood pressure of ≥110 mm Hg were randomized to receive intravenous hydralazine

EvidenceUpdates2018

3. Nifedipine vs Placebo for Treatment of Chronic Chilblains: A Randomized Controlled Trial

Nifedipine vs Placebo for Treatment of Chronic Chilblains: A Randomized Controlled Trial 27621162 2016 09 13 2017 05 03 1544-1717 14 5 2016 Sep Annals of family medicine Ann Fam Med Nifedipine vs Placebo for Treatment of Chronic Chilblains: A Randomized Controlled Trial. 453-9 10.1370/afm.1966 Nifedipine is commonly prescribed for the treatment of chilblains (pernio, perniosis) on the basis of observational studies and a single small, older clinical trial. We aimed to confirm the proposed (...) superiority of oral nifedipine 60 mg per day over placebo for treatment of chronic chilblains in primary care. We performed a randomized, placebo-controlled, double-blind, crossover trial, closely following the design of the older trial. A total of 32 patients with chronic chilblains were randomly assigned to nifedipine (30 mg controlled release twice a day) or placebo. The primary outcome was patient-reported complaints; the secondary outcome was patient-reported disability. Both were assessed from daily

EvidenceUpdates2016

4. Randomised controlled trial: Tamsulosin and nifedipine did not improve stone passage over placebo nor were they cost-effective in ureteric stone disease

Randomised controlled trial: Tamsulosin and nifedipine did not improve stone passage over placebo nor were they cost-effective in ureteric stone disease Tamsulosin and nifedipine did not improve stone passage over placebo nor were they cost-effective in ureteric stone disease | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Tamsulosin and nifedipine did not improve stone passage over placebo nor were they cost-effective in ureteric stone disease Article Text Therapeutics/Prevention Randomised controlled trial Tamsulosin and nifedipine did not improve stone

Evidence-Based Medicine (Requires free registration)2016

5. Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tam

Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tam Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine (...) hydrochloride (Petyme, TEVA UK Ltd) nor nifedipine (Coracten®, UCB Pharma Ltd) increase the likelihood of stone passage over 4 weeks for people with ureteric colic, and use of these drugs is very unlikely to be cost-effective for the NHS. {{author}} {{($index , , , , , , , , , , , , , , , , , & . Robert Pickard, 1 Kathryn Starr, 2 Graeme MacLennan, 2 Mary Kilonzo, 3 Thomas Lam, 4 Ruth Thomas, 2 Jennifer Burr, 5 John Norrie, 2 Gladys McPherson, 2 Alison McDonald, 2 Kirsty Shearer, 2 Katie Gillies, 2 Kenneth

NIHR HTA programme2015

6. Atenolol compared with nifedipine: effect on cognitive function and mood in elderly hypertensive patients.

Atenolol compared with nifedipine: effect on cognitive function and mood in elderly hypertensive patients. Atenolol compared with nifedipine... preview & related info | Mendeley E-mail address Password ( ) Remember me …or sign in with Search Main Navigation › Short URL Annals of Internal Medicine ( 1992 ) Volume: 116 , Issue: 8 , Pages: 615-623 PubMed: Available from or Find this paper at: Abstract OBJECTIVE: To compare the effects of atenolol and nifedipine on mood and cognitive function (...) in elderly hypertensive patients. DESIGN: Randomized, double-blind, crossover trial. PATIENTS: Thirty-one elderly volunteers (7 women and 4 men) 60 to 81 years of age with mild to moderate hypertension were recruited from the general community and a Veterans Affairs hospital hypertension clinic. Six volunteers withdrew at early phases of the study for reasons unrelated to adverse drug effects. INTERVENTIONS: Participants had 2 weeks of placebo, to 6 weeks of titration with atenolol or nifedipine

Annals of Internal Medicine2013

7. Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial.

Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial. 23280223 2013 01 02 2013 01 03 2016 10 17 1538-3598 309 1 2013 Jan 02 JAMA JAMA Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial. 41-7 10.1001/jama.2012.153817 In threatened preterm labor, maintenance tocolysis with nifedipine, after an initial course of tocolysis and corticosteroids for (...) 48 hours, may improve perinatal outcome. To determine whether maintenance tocolysis with nifedipine will reduce adverse perinatal outcomes due to premature birth. APOSTEL-II (Assessment of Perinatal Outcome with Sustained Tocolysis in Early Labor) is a double-blind, placebo-controlled trial performed in 11 perinatal units including all tertiary centers in The Netherlands. From June 2008 to February 2010, women with threatened preterm labor between 26 weeks (plus 0 days) and 32 weeks (plus 2 days

JAMA2013

8. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial

Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial 21985500 2011 12 15 2012 01 30 2013 11 21 1471-0528 119 1 2012 Jan BJOG : an international journal of obstetrics and gynaecology BJOG Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial. 78-85 10.1111/j.1471-0528.2011.03151.x To compare oral nifedipine with intravenous (...) labetalol in their rapidity to control hypertensive emergencies of pregnancy. A double-blind randomised trial. A university hospital in Malaysia. Pregnant women with severe gestational hypertension≥160/110 mmHg who required immediate treatment. Patients were randomised to receive nifedipine (10 mg tablet, orally, up to five doses) and intravenous placebo saline injection or intravenous labetalol injection (in an escalating dose regimen of 20, 40, 80, 80 and 80 mg) and a placebo tablet every 15 minutes

EvidenceUpdates2012

9. Nifedipine in the management of preterm labor: a systematic review and metaanalysis

Nifedipine in the management of preterm labor: a systematic review and metaanalysis Nifedipine in the management of preterm labor: a systematic review and metaanalysis Nifedipine in the management of preterm labor: a systematic review and metaanalysis Conde-Agudelo A, Romero R, Kusanovic JP CRD summary The review concluded that nifedipine appeared to be a more effective tocolytic agent than beta 2 -adrenergic-receptor agonists and better tolerated compared with beta 2 -adrenergic-receptor (...) agonists and magnesium sulfate in women with preterm labour. The review was generally well conducted, but the authors’ conclusions regarding magnesium sulphate may be too strong given the small number of trials included in the analyses. Authors' objectives To determine the efficacy and safety of nifedipine as a tocolytic agent in women with preterm labour. Searching MEDLINE, EMBASE, LILACS, Web of Science, Cochrane Central Register of Controlled Trials (CENTRAL), CINAHL, five registers of ongoing

DARE.2011

10. Nifedipine as a uterine relaxant for external cephalic version: a randomized controlled trial

Nifedipine as a uterine relaxant for external cephalic version: a randomized controlled trial 18669722 2008 08 01 2008 09 16 2013 11 21 0029-7844 112 2 Pt 1 2008 Aug Obstetrics and gynecology Obstet Gynecol Nifedipine as a uterine relaxant for external cephalic version: a randomized controlled trial. 271-6 10.1097/AOG.0b013e31817f1f2e To estimate the effectiveness of nifedipine as a uterine relaxant during external cephalic version to correct breech presentation. In this randomized, double (...) -blind, placebo-controlled trial, women with a singleton fetus in breech presentation and a gestational age of 36 weeks or more were eligible for enrollment. Participating women received two doses of either nifedipine 10 mg or placebo, 30 and 15 minutes before the external cephalic version attempt. The primary outcome was a cephalic-presenting fetus immediately after the procedure. Secondary outcome measures were cephalic presentation at delivery, mode of delivery, and adverse events. A sample size

EvidenceUpdates2008

11. Cost-effectiveness analysis of hypertension treatment: controlled release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension. The Nifedipine and Candesartan Combination (NICE-Combi) study

Cost-effectiveness analysis of hypertension treatment: controlled release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension. The Nifedipine and Candesartan Combination (NICE-Combi) study Cost-effectiveness analysis of hypertension treatment: controlled release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension. The Nifedipine and Candesartan Combination (NICE-Combi) study Cost-effectiveness analysis (...) of hypertension treatment: controlled release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension. The Nifedipine and Candesartan Combination (NICE-Combi) study Fujikawa K, Hasebe N, Kikuchi K, NICE-Combi Study Group Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment

NHS Economic Evaluation Database.2005

12. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial.

Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. 15351192 2004 09 07 2004 09 21 2015 06 16 1474-547X 364 9437 2004 Sep 4-10 Lancet (London, England) Lancet Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. 849-57 Calcium antagonists are widely prescribed (...) for angina pectoris but their effect on clinical outcome is controversial. We aimed to investigate the effect of the calcium antagonist nifedipine on long-term outcome in patients with stable angina pectoris. We randomly assigned 3825 patients with treated stable symptomatic coronary disease to double-blind addition of nifedipine GITS (gastrointestinal therapeutic system) 60 mg once daily and 3840 to placebo. The primary endpoint was the combination of death, acute myocardial infarction, refractory

Lancet2004

13. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). 10972368 2000 09 14 2000 09 14 2015 06 16 0140-6736 356 9227 2000 Jul 29 Lancet (London, England) Lancet Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine (...) GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). 366-72 The efficacy of antihypertensive drugs newer than diuretics and beta-blockers has not been established. We compared the effects of the calcium-channel blocker nifedipine once daily with the diuretic combination co-amilozide on cardiovascular mortality and morbidity in high-risk patients with hypertension. We did a prospective, randomised, double-blind trial in Europe and Israel in 6321 patients aged 55-80 years

Lancet2000

14. Diltiazem, nifedipine, nimodipine or verapamil for neuroleptic-induced tardive dyskinesia.

Diltiazem, nifedipine, nimodipine or verapamil for neuroleptic-induced tardive dyskinesia. BACKGROUND: Tardive dyskinesia (TD) is a potentially disfiguring movement disorder of the orofacial region often caused by use of neuroleptic drugs. A wide range of strategies have been used to help manage TD and, for those who are unable to have their antipsychotic medication stopped or substantially changed, the calcium-channel blocking group of drugs (diltiazem, nifedipine, nimodipine, verapamil) has

Cochrane2000

15. Safety of nifedipine in angina pectoris: a meta-analysis

Safety of nifedipine in angina pectoris: a meta-analysis Safety of nifedipine in angina pectoris: a meta-analysis Safety of nifedipine in angina pectoris: a meta-analysis Stason W B, Schmid C H, Niedzwiecki D, Whiting G W, Caubet J F, Cory D, Luo D, Ross S D, Chalmers T C Authors' objectives To compare cardiovascular event rates in patients with stable angina receiving nifedipine as monotherapy or combination therapy and in active drug controls. Searching MEDLARS (1966 to August 1995 (...) ) was searched using the exploded MESH term "myocardial ischemia" and "nifedipine" as a textword. Studies published in English, French, Italian, German and Spanish languages were included. CD-ROM Current Contents and bibliographies of retrieved articles were also searched. Study selection Study designs of evaluations included in the review Published randomised controlled trials (RCTs) that enrolled a minimum of 10 patients. Specific interventions included in the review Any nifedipine formulation, either

DARE.1999

16. Nifedipine versus ritodrine for suppression of preterm labor: a meta-analysis

Nifedipine versus ritodrine for suppression of preterm labor: a meta-analysis Nifedipine versus ritodrine for suppression of preterm labor: a meta-analysis Nifedipine versus ritodrine for suppression of preterm labor: a meta-analysis Oei S G, Mol B W, de Kleine M J, Brolmann H A Authors' objectives To assess the effectiveness of nifedipine and ritodrine in the suppression of pre-term labour. Searching MEDLINE was searched from January 1966 to November 1998, and EMBASE from January 1980 (...) to November 1998, using the following keywords: 'nifedipine', 'ritodrine' and 'randomised'. Cross-references of selected studies were checked. A formal assessment of publication bias was not possible due to small sample sizes. Study selection Study designs of evaluations included in the review Randomised clinical trials (RCTs) were eligible. Specific interventions included in the review Direct comparisons of ritodrine and nifedipine were eligible. Ritodrine doses (where stated) ranged from an infusion

DARE.1999

17. Clinical and economic outcomes of a nifedipine-to-felodipine switch program

Clinical and economic outcomes of a nifedipine-to-felodipine switch program Clinical and economic outcomes of a nifedipine-to-felodipine switch program Clinical and economic outcomes of a nifedipine-to-felodipine switch program Dearing C J, Briscoe T A, Morgan S M, Block L C Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed (...) critical assessment on the reliability of the study and the conclusions drawn. Health technology Second generation dihydropyridine calcium channel blockers for the treatment of hypertension. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population Patients with hypertension switching from treatment with nifedipine to treatment with felodipine. Setting Outpatient clinic. The economic analysis was conducted in Atlanta, Georgia, USA. Dates to which data relate

NHS Economic Evaluation Database.1998

18. Meta-analysis of the long-term effect of nifedipine for pulmonary hypertension

Meta-analysis of the long-term effect of nifedipine for pulmonary hypertension Meta-analysis of the long-term effect of nifedipine for pulmonary hypertension Meta-analysis of the long-term effect of nifedipine for pulmonary hypertension Malik A S, Warshafsky S, Lehrman S Authors' objectives Assess the magnitude and consistency of the effect of nifedipine on reducing pulmonary artery pressure (PAP) in patients with pulmonary hypertensive disorders. Searching MEDLINE was searched from 1966 (...) to 1995 using the keywords field for the combination 'nifedipine' and 'pulmonary hypertension'. Bibliographies of retrieved articles were also reviewed. Study selection Study designs of evaluations included in the review Case series were included. Specific interventions included in the review Nifedipine (30 to more than 200 mg/day). Participants included in the review Patients with the following illnesses were included in the analysis: pulmonary hypertension secondary to

DARE.1997

19. Nifedipine et insuffisance coronarienne: raisons d'une controverse [Nifedipine and coronary heart disease: reasons for controversy]

Nifedipine et insuffisance coronarienne: raisons d'une controverse [Nifedipine and coronary heart disease: reasons for controversy] Nifedipine et insuffisance coronarienne: raisons d'une controverse [Nifedipine and coronary heart disease: reasons for controversy] Nifedipine et insuffisance coronarienne: raisons d'une controverse [Nifedipine and coronary heart disease: reasons for controversy] Lievre M, Cucherat M Authors' objectives The authors state that their objective is to assess criticisms (...) levied at a previously published meta-analysis of nifedipine for coronary heart disease (Furberg et al 1995 - see Other Publications of Related Interest). However, they also appear to have attempted to extend the review, in order to provide additional data. Searching Data were used from the review by Furberg et al 1995 (see Other Publications of Related Interest). Other sources included MEDLINE (search terms and years searched not provided) and handsearching of English, French, Italian, Spanish

DARE.1997

20. Safety of nifedipine in patients with hypertension: a meta-analysis

Safety of nifedipine in patients with hypertension: a meta-analysis Safety of nifedipine in patients with hypertension: a meta-analysis Safety of nifedipine in patients with hypertension: a meta-analysis Stason W B, Schmid C H, Niedzwiecki D, Whiting G W, Caubet J-F, Luo D, Ross S D, Chalmers T C Authors' objectives To compare cardiovascular event rates in patients with mild or moderate hypertension who received nifedipine with active drug controls. Searching MEDLARS was searched from 1966 (...) to August 1995 using the MeSH 'hypertension' and 'nifedipine' as a textword. Studies published in English, French, Italian, German or Spanish were included. Current Contents (CD-ROM), and the bibliographies of retrieved articles were also searched. Study selection Study designs of evaluations included in the review Randomised controlled trials (RCTs) were included if they had a minimum of 10 patients, were published in a peer-reviewed journal or supplement to such a journal, and reported adverse events

DARE.1997